Results 101 to 110 of about 34,384 (251)

Red-cell Aplasia in Marasmus and Kwashiorkor [PDF]

, 1962
Athena Kondi, S Mehta, Henry Foy
openalex   +1 more source

BTK Inhibitor Synergizes With CD19‐Targeted Chimeric Antigen Receptor‐T Cells in Patients With Relapsed or Refractory B‐Cell Lymphoma: An Open‐Label Pragmatic Clinical Trial

Cancer Medicine, Volume 14, Issue 20, October 2025.
ABSTRACT Background CD19‐targeted chimeric antigen receptor‐T cell (CART19) therapy is clinically effective in patients with relapsed or refractory B‐cell lymphoma (BCL), but treatment failure and recurrence need to be overcome. Preclinical studies demonstrated that Bruton tyrosine kinase inhibitor (BTKi) improved the efficacy of CART19 therapy ...
Wenjing Luo, Yinqiang Zhang, Chenggong Li, Jia Xu, Zhuolin Wu, Xindi Wang, Yun Kang, Danying Liao, Haiming Kou, Wei Xie, Wei Xiong, Jun Deng, Heng Mei, Yu Hu   +13 more
wiley   +1 more source

Thymic Tumours with Red Cell Aplasia [PDF]

, 1965
A. Gregson Norman
openalex   +1 more source

Transverse Sinus Hypoplasia as a Differential Diagnosis for Cerebral Vein Thrombosis: A Case Report

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT We present a 43‐year‐old female who had a history of deep vein thrombosis (DVT) and pulmonary emboli and was diagnosed with DVT. The patient reported a headache and underwent an emergency CT scan, which revealed no intracranial hemorrhage (ICH).
Hamidreza Ashayeri, Fateme Javanali Azar, Hadi Vahedi, Ariodad Ranji‐Amjad, Ali Jafarizadeh   +4 more
wiley   +1 more source

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B‐cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Hematotoxicity after anti‐CD19 chimeric antigen receptor T‐cell therapy has drawn attention for potential long‐term effects, and yet, recovery of lymphocyte subsets and immunoglobulin levels beyond B‐cell aplasia remains poorly understood. We retrospectively analyzed 76 consecutive axicabtagene ciloleucel (axi‐cel) recipients with relapsed ...
André Airosa Pardal, Ana Benzaquén, Pablo Granados, Paula Amat, Rafael Hernani, Aitana Balaguer‐Roselló, Ariadna Pérez, Marta Villalba, Pedro Asensi, Blanca Ferrer, Lourdes Cordón, Irene Pastor‐Galán, Juan Montoro, María José Remigia, Juan Carlos Hernández‐Boluda, Amparo Sempere, Jaime Sanz, María José Terol, Carlos Solano, Pedro Chorão, José Luis Piñana   +20 more
wiley   +1 more source

EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Mantle cell lymphoma (MCL) is a relatively rare B‐cell lymphoma subtype, with a higher incidence among males and a median age of 70 years at diagnosis. MCL is characterized by clinically diverse behavior, from indolent disease to extremely aggressive, related to the presence of biological risk factors such as proliferation rate and TP53 ...
Mats Jerkeman, Igor Aurer, Elias Campo, Chan Y. Cheah, Jonathan Clark, Jeanette Doorduijn, Toby A. Eyre, Martin Fehr, Eva Giné, Maria Gomes da Silva, Pavel Klener, Marco Ladetto, Vincent Ribrag, Ofer Shpilberg, Jan Walewski, Martin Dreyling, the EHA Guidelines Committee and the European MCL Network   +16 more
wiley   +1 more source

Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 5, October 2025.
ABSTRACT Background Spinal muscular atrophy (SMA) is a neuromuscular disease caused by loss of survival of motor neuron (SMN) protein inducing progressive muscle weakness and atrophy due to motor neurons degeneration. Despite benefits of SMN restoration therapies in patients, motor defects are still persistent.
Cynthia Bézier, Steve Cottin, Parvin Nazari Hashemi, Mirella El Khoury, Zoé Clerc, Christine Balducci, Delphine Sapaly, Laure Weill, René Lafont, Stanislas Veillet, Pierre J. Dilda, Frédéric Charbonnier, Mathilde Latil, Olivier Biondi   +13 more
wiley   +1 more source

Bone marrow aplasia after infectious hepatitis treated by bone marrow transplantation. [PDF]

, 1974

openalex   +1 more source

Optic nerve aplasia

Indian Journal of Ophthalmology, 2018
Ruchir Tewari, Divya Kumari, Vinod Kumar
openaire   +4 more sources

Late‐Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T‐Cell Therapy

eJHaem, Volume 6, Issue 5, October 2025.
ABSTRACT Introduction Invasive fungal infection (IFI) after chimeric antigen receptor (CAR) T‐cell therapy is less common than bacterial and viral infections, but can be fatal once it develops. As most cases occur within 30 days after CAR T‐cell infusion, late‐onset IFI—particularly mould infection—appears to be under‐recognised.
Daisuke Ikeda, Tomohiro Nawada, Takumi Kondo, Takayuki Shinohara, Tomohiro Nagano, Saya Kubota, Ryuichiro Hiyama, Masaya Ueno, Hiroki Kobayashi, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Masanori Makita, Yoshinobu Maeda   +16 more
wiley   +1 more source